Latest News for: drug therapy

Edit

Essential Thrombocythemia Market Set for Significant Growth Across 7MM | DelveInsight

GetNews 21 Mar 2025
This represents a notable advancement as currently, there is only one drug specifically approved for ET treatment in Europe, with no FDA-approved therapies in the United States ... Essential Thrombocythemia Marketed Therapies.
Edit

Investors shift focus from gene therapy to lucrative weight-loss drugs

The News International 21 Mar 2025
Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward medical sectors like obesity and cancer, as sales for some of the new treatments fall short.
Edit

Open Angle Glaucoma Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports ...

GetNews 21 Mar 2025
To Know in detail about the Open Angle Glaucoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; ... The analysis covers Open Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Personalized Healthcare Industry: Growth, Trends, and Future Insights (2025-2034)

Pharmiweb 21 Mar 2025
Next-Generation Sequencing (NGS) Big Data Analytics Bioinformatics Drug Discovery Companion Diagnostics ... Newer applications of biopharmaceutical development include CRISPR-based therapies or AI-based drug discovery platforms like BenevolentAI.
Edit

HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma

Pharmiweb 21 Mar 2025
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM.​HCM; HKEX.​13) today announces that the New Drug Application (“NDA”) for TAZVERIK® (tazemetostat) has been granted conditional approval in China for ...
Edit

New Alzheimer's drug offered to Summit Township man. 'It does give us hope'

GoErie 21 Mar 2025
Leqembi is an infusion therapy approved by the Food and Drug Administration in 2023 ... Leqembi and a similiar drug, Kisunla, do not work for every dementia patient.
Edit

Jeff Baena’s tragic death leaves fans in shock after split from Aubrey Plaza: new details revealed

The Times of India 21 Mar 2025
Since then, Baena had been receiving professional help through therapy.The autopsy findings revealed that there were no traces of drugs or alcohol in Baena’s system at the time of his death.
Edit

Achondroplasia Market on Track for Major Expansion by 2034, According to DelveInsight | Sanofi, Changchun ...

GetNews 20 Mar 2025
To Know in detail about the Achondroplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; ... The analysis covers Achondroplasia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Fabry Disease Market Growth Projections 2023-2032: DelveInsight Analysis | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, ...

GetNews 20 Mar 2025
FDA has granted Orphan Drug Designation (ODD) to EXG110, an innovative gene therapy for ... The analysis covers Fabry Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Schizophrenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, ...

GetNews 20 Mar 2025
... therapies, and the projected size of the Schizophrenia market from 2020 to 2034 ... The analysis covers the Schizophrenia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Traumatic Brain Injury Drug Market 2034: Clinical Trials, EMA, PDMA, FDA Approval, Medication, Epidemiology, Therapies ...

GetNews 20 Mar 2025
Ongoing research in Traumatic Brain Injury focuses on neuroprotective drugs, stem cell therapy, and advanced rehabilitation techniques to enhance recovery ... uptake by therapies, and sales of each drug.
Edit

Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | ...

GetNews 20 Mar 2025
This value is projected to rise substantially with the launch of new therapies ... Key Multiple System Atrophy Therapies ... The analysis covers Multiple System Atrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Parainfluenza Virus Infection Market to Expand Significantly by 2034, States DelveInsight Report | Ansun Biopharma, ...

GetNews 20 Mar 2025
Key Parainfluenza Virus Infection Therapies ... Parainfluenza Virus Infection Drugs Uptake and Pipeline Development Activities ... The analysis covers Parainfluenza Virus Infection market uptake by drugs, patient uptake by therapies, and sales of each drug.
Edit

Measures facilitate approval of 48 first-in-class innovative drugs

ECNS 20 Mar 2025
... pathway, 11 gained conditional market approval and 13 were included in breakthrough therapy programs during clinical trials, according to the report from the administration's drug evaluation center.
×